4//SEC Filing
McCulloch Kevin 4
Accession 0001867096-24-000144
CIK 0001867096other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 5:22 PM ET
Size
6.9 KB
Accession
0001867096-24-000144
Insider Transaction Report
Form 4
McCulloch Kevin
See Remarks
Transactions
- Award
Stock Appreciation Right
2024-08-01+200,000→ 200,000 totalExercise: $2.43Exp: 2026-09-01→ Common Stock (200,000 underlying) - Award
Common Stock
2024-08-01+150,000→ 1,601,953 total
Footnotes (2)
- [F1]The award will vest in full on the two-year anniversary of the grant date.
- [F2]Upon exercise, the Stock Appreciation Right will be settled in cash.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0002031695
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 5:22 PM ET
- Size
- 6.9 KB